Drug Delivery: Advances in drug delivery vehicles and devices - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Drug Delivery
Tablets & capsules, liquid-dosage forms. Inhalables & intranasals. Injectables: intravenous, intramuscular & subcutaneous. Nanotechnology, dissolvable films and tablets & radio frequency transdermal drug delivery.

Week of Aug. 30, 2010: Company and People Notes: Lonza Acquires Vivante; PPD Appoints VP of Quality Management; And More.

September 2, 2010
ePT--the Electronic Newsletter of Pharmaceutical Technology

Company and People Notes: Lonza Acquired Vivante; PPD Appoints VP of Quality Management; And More.

Understanding The Requirements For Effective Nasal Drug Delivery

September 1, 2010

Pharmaceutical Technology Europe

One particularly crucial parameter for nasal sprays is the size of the droplets produced during actuation, which can potentially impact bioavailability.

Strong Growth Predicted for Global Vaccine Market

August 26, 2010

ePT--the Electronic Newsletter of Pharmaceutical Technology

Two new reports describe the vaccine market's recent growth and predict future market expansions.

Week of Aug. 23, 2010: Company and People Notes: Quark and Novartis Form Agreement; Hospira CEO Retires; And More.

August 26, 2010
ePT--the Electronic Newsletter of Pharmaceutical Technology

Week of Aug. 23, 2010: Company and People Notes: Quark and Novartis Form Agreement; Hospira CEO Retires; And More.

Week of Aug. 16, 2010: Company and People Notes: Eli Lilly Ends Semagacestat Program; Selecta Appoints CEO; And More.

August 19, 2010
ePT--the Electronic Newsletter of Pharmaceutical Technology

Eli Lilly Ends Semagacestat Program; Selecta Appoints CEO; And More.

Week of Aug. 9, 2010: Company and People Notes: Penwest and Endo to Merge; Watson Makes Senior Appointments; And More.

August 12, 2010
ePT--the Electronic Newsletter of Pharmaceutical Technology

Penwest and Endo to Merge; Watson Makes Senior Appointments; And More.

FDA Recommends Reducing Residual Drug in Transdermal Delivery Systems

August 5, 2010

ePT--the Electronic Newsletter of Pharmaceutical Technology

In a draft guidance published this week, the US Food and Drug Administration recommended that makers of transdermal and transmucosal drug-delivery systems use "an appropriate scientific approach" during product design, development, and manufacturing to minimize the amount of residual drug substance present at the end of the products' labeled use periods.

Week of August 2, 2010: Company and People Notes: FDA Approves Flu Vaccines; Caraco Names COO; And More.

August 5, 2010
ePT--the Electronic Newsletter of Pharmaceutical Technology

FDA Approves Flu Vaccines; Caraco Names COO; And More.

Developing siRNA Therapies: A Technical Forum

August 2, 2010

Pharmaceutical Technology

Pharmaceutical Technology talked to experts in siRNA-drug development to gain insight into the characteristics, processes, and challenges of this class of therapeutics.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
Click here